Abstract
Commercial applications of molecular genetics and cell biology have resulted in a flurry of entrepreneurial activities among academic biologists and universities eager to cash in on the financial side of this technological revolution. The situation is not unique to biology. It is following the path of other disciplines that have formed close partnerships with industry, including nuclear and petroleum engineering, computer sciences, nutrition, electronics, and chemistry. Nevertheless, the current debate that has centered on the commercial ties of academic biologists has been more widely publicized than at any time in the past. Several hypotheses may be offered to explain this phenomenon.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Weiner, C. (1984) (personal communication).
Office of Technology Assessment, Commercial Biotechnology: An International Analysis ,U.S. Government Printing Office, Washington, DC (Jan. 1984).
Subcommittee on Investigations and Oversight, Committee on Science and Technology, U.S. House of Representatives, Hearings on Commercialization of Academic Biomedical Research ,U.S. Government Printing Office, Washington, DC (June 8–9, 1981).
California Rural Legal Assistance vs. Board of Trustees of the University of California. Brief filed in the California Judicial Court, 1984.
Subcommittee on Investigations and Oversight, Committee on Science and Technology, U.S. House of Representatives, Hearings on University/Industry Cooperation in Biotechnology ,U.S. Government Printing Office, Washington, DC (July 16–17, 1982); and supra note 3.
See supra note 2.
Supra note 2, at 417.
Walsh, J., Universities: Industry links raise conflict of interest issue, Science 164:411–2 (Apr. 25, 1969).
Id. at 412.
Cone, J. and Robinson, J. DBCP-UC Research, Synapse ,San Francisco, CA: University of California at San Francisco, 22(9):4, 1 (Nov. 10, 1977).
Orr, L. (ed.), Corporate money and co-opted scholars, Business and Society Rev. 37:4–11 (Spring 1980–1981), at 5.
Genetic Engineering News (M. Liebert, publisher, in letter to readers) 3(6):4 (Nov./Dec. 1983).
Culliton, B., The academic-industrial complex, Science 216:960 (May 28, 1982).
Biogen, N. V., Company Prospectus (1983).
Centocor, Inc., Company Prospectus (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Aubrey Milunsky and George J. Annas
About this chapter
Cite this chapter
Krimsky, S. (1985). The Corporate Capture of Academic Science and Its Social Costs. In: Milunsky, A., Annas, G.J. (eds) Genetics and the Law III. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4952-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4952-5_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4954-9
Online ISBN: 978-1-4684-4952-5
eBook Packages: Springer Book Archive